Analysts expect K2M Group Holdings (NASDAQ:KTWO) to announce sales of $70.90 million for the current quarter, according to Zacks. Three analysts have made estimates for K2M Group’s earnings, with the highest sales estimate coming in at $71.70 million and the lowest estimate coming in at $70.00 million. K2M Group posted sales of $65.69 million during the same quarter last year, which suggests a positive year over year growth rate of 7.9%. The business is scheduled to issue its next quarterly earnings results on Tuesday, August 7th.
According to Zacks, analysts expect that K2M Group will report full-year sales of $284.59 million for the current financial year, with estimates ranging from $284.00 million to $284.97 million. For the next fiscal year, analysts anticipate that the company will post sales of $313.84 million per share, with estimates ranging from $312.31 million to $316.80 million. Zacks’ sales calculations are an average based on a survey of analysts that follow K2M Group.
K2M Group (NASDAQ:KTWO) last posted its quarterly earnings results on Wednesday, February 28th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01). K2M Group had a negative net margin of 14.27% and a negative return on equity of 15.38%. The business had revenue of $67.80 million for the quarter, compared to analysts’ expectations of $67.70 million.
Several analysts have issued reports on KTWO shares. BidaskClub upgraded shares of K2M Group from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Oppenheimer set a $24.00 price target on shares of K2M Group and gave the company a “buy” rating in a research report on Thursday, March 1st. Needham & Company LLC restated a “buy” rating and set a $23.00 price target on shares of K2M Group in a research report on Wednesday, May 2nd. Finally, ValuEngine upgraded shares of K2M Group from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $24.50.
K2M Group traded up $0.49, hitting $23.73, during trading on Wednesday, according to MarketBeat.com. 152,800 shares of the company’s stock traded hands, compared to its average volume of 257,572. The company has a quick ratio of 1.38, a current ratio of 2.79 and a debt-to-equity ratio of 0.34. K2M Group has a 12-month low of $16.44 and a 12-month high of $25.99. The firm has a market cap of $994.19 million, a price-to-earnings ratio of -27.28 and a beta of 1.47.
Several institutional investors have recently bought and sold shares of KTWO. Engineers Gate Manager LP purchased a new stake in shares of K2M Group during the first quarter worth about $190,000. Teacher Retirement System of Texas purchased a new stake in shares of K2M Group during the fourth quarter worth about $213,000. Natixis Advisors L.P. purchased a new stake in shares of K2M Group during the first quarter worth about $229,000. MetLife Investment Advisors LLC purchased a new stake in shares of K2M Group during the fourth quarter worth about $350,000. Finally, Oppenheimer Asset Management Inc. boosted its holdings in shares of K2M Group by 18.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 19,285 shares of the medical device company’s stock worth $366,000 after purchasing an additional 2,942 shares during the period.
K2M Group Company Profile
K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.